Consolidated Statement Of Cash Flows

Cyfuse Biomedical K.K. - Filing #7272238

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-794,017,000 JPY
-678,354,000 JPY
Income taxes paid
-2,542,000 JPY
-2,441,000 JPY
Interest paid
-9,941,000 JPY
-9,735,000 JPY
Net cash provided by (used in) operating activities
-760,553,000 JPY
-562,296,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-7,612,000 JPY
-19,474,000 JPY
Net cash provided by (used in) investing activities
-8,637,000 JPY
-19,474,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
16,190,000 JPY
22,880,000 JPY
Repayments of long-term borrowings
-18,000,000 JPY
-77,824,000 JPY
Net cash provided by (used in) financing activities
-52,012,000 JPY
18,236,000 JPY
Net increase (decrease) in cash and cash equivalents
-821,203,000 JPY
-563,534,000 JPY
Cash and cash equivalents
2,052,570,000 JPY
2,873,773,000 JPY
3,437,307,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.